Clinical and ultrasonographic evaluation of the window of opportunity for retreatment with rituximab in rheumatoid arthritis patients from a multicentre real-life study

Autor: Olivier Vittecoq, Marie Kozyreff-Meurice, Estelle Houivet, Nathalie Leon, Laure Berard, Maud Gauthier-Prieur, Sophie Pouplin, Gilles Avenel, Pauline Brevet, Jacques Benichou, Paul Michelin, Christian Marcelli, Thierry Lequerre

Publikováno v: Clinical and experimental rheumatology.

To determine a potential window of opportunity for retreatment with rituximab in patients with rheumatoid arthritis (RA) from a multicentre longitudinal real-life study based on tight monitoring with ultrasonography (US).Thirty RA patients treated wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8923801b985d9c0f413d4dc487484004
https://pubmed.ncbi.nlm.nih.gov/36377584

Le syndrome d’Hajdu-Cheney ou acro-ostéolyse autosomique dominante

Autor: Nathalie Leon, Quitterie Rochoux, Christian Marcelli

Publikováno v: Revue du Rhumatisme Monographies. 86:132-137

Resume Le syndrome d’Hajdu-Cheney (SHC) ou acro-osteolyse autosomique dominante, est une dysplasie cranio-squelettique tres rare, caracterisee principalement par une petite taille, une acro-osteolyse des phalanges distales revelee par un pseudo-hip

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b6170068496291c7ec665e6bcea3dcda
https://doi.org/10.1016/j.monrhu.2018.11.007

Nivolumab Causing a Polymyalgia Rheumatica in a Patient With a Squamous Non–Small Cell Lung Cancer

Autor: Sophie Fedrizzi, Cyril Guillaumé, Jeannick Madelaine, Joachim Alexandre, Marion Sassier, Florian Lecaignec, Léa Hamel-Sénécal, Basile Chrétien, Marjorie Bernier, Nathalie Leon, Xavier Humbert

Publikováno v: Journal of Immunotherapy. 40:129-131

The anti-programmed cell-death-1 antibody, nivolumab, has been recently approved for the treatment of advanced non-small cell lung cancer. Although, today, immune-related adverse effects such as dermatologic, digestive, hepatic, and endocrine toxicit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd9db64312ad91aa96cfe5a5b558a2d2
https://doi.org/10.1097/cji.0000000000000163

A case of Hajdu-Cheney syndrome associated with psoriatic rheumatism, two causes of acro-osteolysis

Autor: Christian Marcelli, Philippe Orcel, Anne-Claire Bréhin, Murielle Michel, Quitterie Rochoux, Nathalie Leon

Publikováno v: Joint Bone Spine
Joint Bone Spine, Elsevier Masson, 2018, 85 (4), pp.493-494. ⟨10.1016/j.jbspin.2017.05.025⟩

Joint Bone Spine - In Press.Proof corrected by the author Available online since mardi 11 juillet 2017

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13cebf19f011deafbeba56684c37852a
https://doi.org/10.1016/j.jbspin.2017.05.025

Efficacy of Azacitidine in Autoimmune and Inflammatory Disorders associated with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Autor: Olivier Fain, Olivier Decaux, Jean-Baptiste Fraison, Olivier Lortholary, Nathalie Leon, Anne-Laure Buchdahl, Claude Gardin, Achille Aouba, Pierre Fenaux, Gwenola Maigne, Guillaume Denis, Eric Liozon, Sabine Berthier, Sophie Park, Arsène Mekinian, Jean-Benoit Arlet, Jean-Emmanuel Kahn, Eric Grignano, Julien Rossignol, Mohamed Omouri, Thorsten Braun

Publikováno v: Leukemia Research
Leukemia Research, 2016, 43, pp.13-17. ⟨10.1016/j.leukres.2016.02.005⟩
Leukemia Research, Elsevier, 2016, 43, pp.13-17. ⟨10.1016/j.leukres.2016.02.005⟩
Leukemia Research, Elsevier, 2016, 43, pp.13-17. 〈10.1016/j.leukres.2016.02.005〉

International audience; This retrospective study describes efficacy of Azacitidine on autoimmune disorders (AID) associated with MDS/CMML in 22 patients. Response of AID to Azacitidine was observed in 19 patients (86%). Reduction or discontinuation o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02413b5da1ed37bc359b51c9d383a67a
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01278608/document